This makes alot more sense than the dribble that the sky is falling! The idea behind a drug with many arms, such as Brilacidin, is to get the easiest/cheapest ones to a point that show effectiveness, value of the entire line. If they can get B-UP approved, it's worth more than B-ABSSSI and Leo has suggested that. So it only makes sense not to dilute more than you have to and get a more valuable indications to the partnering level.

GLTM